AR058328A1 - USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION - Google Patents

USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION

Info

Publication number
AR058328A1
AR058328A1 ARP060105477A ARP060105477A AR058328A1 AR 058328 A1 AR058328 A1 AR 058328A1 AR P060105477 A ARP060105477 A AR P060105477A AR P060105477 A ARP060105477 A AR P060105477A AR 058328 A1 AR058328 A1 AR 058328A1
Authority
AR
Argentina
Prior art keywords
paliperidone
treatment
mental disorder
reduced hepatic
psychiatric patient
Prior art date
Application number
ARP060105477A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/534,623 external-priority patent/US20070197591A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR058328A1 publication Critical patent/AR058328A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método para el tratamiento de pacientes psiquiátricos que padecen o tienen riesgo de deterioro hepático, que comprende administrar una cantidad terapéuticamente efectiva de paliperidona, sus sales de adicion con ácidos, formas enantioméricas y ésteres de la misma aceptables para su uso farmacéutico a pacientes psiquiátricos que lo necesitan.A method for the treatment of psychiatric patients suffering from or at risk of hepatic impairment, which comprises administering a therapeutically effective amount of paliperidone, its acid addition salts, enantiomeric forms and esters thereof acceptable for pharmaceutical use to psychiatric patients who they need it.

ARP060105477A 2005-12-12 2006-12-12 USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION AR058328A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74951505P 2005-12-12 2005-12-12
US74522906P 2006-04-20 2006-04-20
US11/534,623 US20070197591A1 (en) 2005-12-12 2006-09-22 Use of paliperidone for the treatment of a mental disorder in a psychiatric patient with reduced hepatic function

Publications (1)

Publication Number Publication Date
AR058328A1 true AR058328A1 (en) 2008-01-30

Family

ID=38429089

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105477A AR058328A1 (en) 2005-12-12 2006-12-12 USE OF PALIPERIDONE FOR THE TREATMENT OF A MENTAL DISORDER IN A PSYCHIATRIC PATIENT WITH REDUCED HEPATIC OPERATION

Country Status (4)

Country Link
AR (1) AR058328A1 (en)
PE (1) PE20070749A1 (en)
TW (1) TW200800216A (en)
UY (1) UY30007A1 (en)

Also Published As

Publication number Publication date
UY30007A1 (en) 2007-03-30
PE20070749A1 (en) 2007-08-11
TW200800216A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
EA200802208A1 (en) APPLICATION OF FLIBANSTERIN FOR THE TREATMENT OF DISEASES OF THE SEXUAL TREATMENT IN THE POST-CLIMACTERNIC PERIOD
AR091876A1 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
AR050623A1 (en) METHOD FOR THE TREATMENT OF THE ATTENTION DEFICIT HYPERACTIVITY DISORDER
MX2009013574A (en) Modified release solid or semi-solid dosage forms.
CL2010000188A1 (en) A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.
AR047841A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE-INFLAMMATORY DISORDERS
CL2007002526A1 (en) A MEDICINAL PRODUCT THAT INCLUDES, SEPARATE OR TOGETHER: A) A GLYCOPIRRON SALT; B) A BETA-2 ADRENO-RECEIVER AGONIST SELECTED FROM SALMETEROL AND FORMOTEROL; AND C) A CORTICOSTEROID; PHARMACEUTICAL KIT; AND USE IN THE TREATMENT OF AN INFL DISEASE
ATE540690T1 (en) INSULIN COMBINATIONS
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
UY31609A1 (en) "(-) ACID 2- [1- (7-METHYL-2- (MORFOLIN-4-IL) 4-OXO-4H-PIRIDO [1,2-A] PYRIMIDIN-9-IL) ETHYLAMINE] ENANTIOMERICALLY PURE BENZOIC, ITS USE IN MEDICAL THERAPY, AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT-026. "
AR065392A1 (en) METHODS FOR TREATMENT BY INHALATION OF A DISEASE OR RESPIRATORY STATE
EA201270071A1 (en) A METHOD OF TREATING A PATIENT NEEDING ASPIRIN TREATMENT
MX2009004017A (en) The uses of the carboxy-amido-triazole compounds and salts thereof.
DK2043637T3 (en) Methods and Medications for the Administration of ibuprofen
AR087744A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
ATE505203T1 (en) PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
AR061446A1 (en) USE OF 1,7-DIMETHYLXANTINE FOR THE MANUFACTURE OF A NON-ANIOIOUS PSYCHOANALEPTIC DRUG FOR THE TREATMENT OF A NEUROPSYCHIATRIC DISORDER
CL2007003643A1 (en) PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS.
AR111374A1 (en) USE OF LIK066 IN PATIENTS WITH HEART FAILURE
SG141358A1 (en) Treatment of psychiatric patients with reduced heptaic function with paliperidone
CL2011001258A1 (en) Citric acid addition salts of (r) -5 - ((e) -2-pyrrolidin-3-yl vinyl) pyrimidine; polymorphic monoitrate forms; pharmaceutical composition that includes them; and its use in the prevention or treatment of pain, inflammation or a disorder of the central nervous system.
AR053928A1 (en) REACTIVE METHODS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
CR9200A (en) USE OF A 5-HT6 AGONIST FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease

Legal Events

Date Code Title Description
FB Suspension of granting procedure